According to previous studies proposing that cancer cells with STIM1 upregulation display better cell migration ability, we hypothesized that cancer cells overexpressing constitutively active STIM1 (D76A form) would exhibit better migration abilities, while those with dominant negative STIM1 (D76A-ΔERM form) would show decreased migration abilities. This evidence concerns the gene STIM1 and cancer.